VYNE THERAPEUTICS INC. (VYNE) Operating margin 2016–2025
VYNE THERAPEUTICS INC. (VYNE) operating margin by fiscal year — reported operating income divided by reported revenue.
-5219.1%FY2025 · since FY2016: -2126.4% → -5219.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -5219.1% | +3490.9 pp |
| FY2024 | -8710.0% | -1809.5 pp |
| FY2023 | -6900.5% | +289.3 pp |
| FY2022 | -7189.7% | -3010.2 pp |
| FY2021 | -4179.5% | -2976.5 pp |
| FY2020 | -1203.0% | +20438.8 pp |
| FY2019 | -21641.8% | -19558.5 pp |
| FY2018 | -2083.2% | -1437.4 pp |
| FY2017 | -645.9% | +1480.6 pp |
| FY2016 | -2126.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice